Cécile Holweg

Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials

Nicola A. Hanania, Phillip E. Korenblat, Kenneth R. Chapman et al. · The Lancet Respiratory Medicine · 2016 · 466 citations

Medicine, Internal Medicine, Pharmacology +10

Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies

Nicola A. Hanania, Michael Noonan, Jonathan Corren et al. · Thorax · 2015 · 377 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

Synovial phenotypes in rheumatoid arthritis correlate with response to biologic therapeutics

Glynn Dennis, Cécile Holweg, Sarah Kummerfeld et al. · Arthritis Research & Therapy · 2014 · 373 citations · Full text

Medicine, Immunology, Internal Medicine +17

U-BIOPRED clinical adult asthma clusters linked to a subset of sputum omics

Diane Lefaudeux, Bertrand De Meulder, Matthew J. Loza et al. · Journal of Allergy and Clinical Immunology · 2016 · 292 citations · Full text

Life Sciences, Bioinformatics, Biomedical Informatics +14

Epithelial IL-6 trans-signaling defines a new asthma phenotype with increased airway inflammation

Zala Jevnikar, Jörgen Östling, Elisabeth Ax et al. · Journal of Allergy and Clinical Immunology · 2018 · 193 citations · Full text

Life Sciences, Immunology, Cellular Immunology +13